NCT00209937View on ClinicalTrials.gov

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

PHASE3CompletedINTERVENTIONAL

Enrollment

675

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

June 30, 2004

Conditions

Primary Insomnia

Interventions

DRUG

Gaboxadol

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT00209937 - A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia | Biotech Hunter | Biotech Hunter